Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Belite Bio, Inc - American Depositary Shares
(NQ:
BLTE
)
165.29
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Belite Bio, Inc - American Depositary Shares
< Previous
1
2
3
4
Next >
InvestorNewsBreaks – Belite Bio, Inc (NASDAQ: BLTE) Prices $350M Underwritten Public Offering of ADSs
December 05, 2025
Via
Investor Brand Network
Belite Bio Announces Pricing of $350.0 Million Underwritten Public Offering of American Depositary Shares
December 01, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio Announces Proposed Underwritten Public Offering of American Depositary Shares
December 01, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
New Hope for People Living with a Disease Once Deemed Untreatable: Belite Bio Announces Positive Topline Results from the Pivotal Global, Phase 3 DRAGON Trial of Tinlarebant in Adolescents with Stargardt Disease
December 01, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
November 10, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
November 05, 2025
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results
November 03, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio Announces UK’s Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
November 02, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
CORRECTION -- International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025
October 31, 2025
From
Virtual Investor Conferences
Via
GlobeNewswire
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025
October 30, 2025
From
Virtual Investor Conferences
Via
GlobeNewswire
Belite Bio to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference November 4th
October 29, 2025
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
From
Virtual Investor Conferences; Belite Bio, Inc
Via
GlobeNewswire
Belite Bio to Participate in the Deutsche Bank ADR Virtual Investor Conference
October 29, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio to Participate in the 2025 Maxim Growth Summit
October 16, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio Announces China NMPA Agrees to New Drug Application with Priority Review based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
October 15, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease
September 12, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio Announces Up to $275 Million Upsized Private Placement Financing by Leading Healthcare Investors
September 08, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio to Participate in Three Upcoming Investor Conferences
August 27, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
August 11, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio Announces Registered Direct Offering of $15 Million
August 07, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio to Participate in the H.C. Wainwright Annual Ophthalmology Virtual Conference
August 06, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio to Host Webcast on August 11, 2025, to Discuss Second Quarter 2025 Financial Results
August 04, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio to Participate in the BTIG Virtual Biotechnology Conference
July 23, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy
July 02, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio Announces FDA Granting of Breakthrough Therapy Designation for Tinlarebant for the Treatment of Stargardt Disease
May 21, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
May 16, 2025
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Belite Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 13, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio, Inc to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference May 15th
May 12, 2025
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Belite Bio to Participate in Four Upcoming Investor Conferences
May 12, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
UPDATE - International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025
May 08, 2025
From
Virtual Investor Conferences
Via
GlobeNewswire
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025
May 08, 2025
From
Virtual Investor Conferences
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
